Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.65 HKD | +0.22% |
|
-1.52% | +62.95% |
Jul. 12 | Fosun Pharma Receives Offers for Share Alternative Offer Related to Henlius Merger Offer | MT |
Jul. 02 | Shanghai Henlius Biotech Gets the Nod from Japan's PMDA for Japan Trials | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+62.95% | 1.58B | |
+6.96% | 101B | |
+8.29% | 42.63B | |
-11.09% | 33.5B | |
+82.32% | 29.77B | |
-11.82% | 16.14B | |
+1.39% | 14.31B | |
-12.13% | 11.55B | |
+176.65% | 10.53B | |
+6.74% | 9.2B |
- Stock Market
- Equities
- 2696 Stock
- News Shanghai Henlius Biotech, Inc.
- Henlius Biotech Gets US FDA Clearance for Phase 3 Trial of Gastric Cancer Combination Therapy